Goldman Sachs’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.24M Sell
63,722
-21,133
-25% -$2.4M ﹤0.01% 2515
2025
Q1
$8.92M Sell
84,855
-25,754
-23% -$2.71M ﹤0.01% 2312
2024
Q4
$11.9M Buy
110,609
+15,356
+16% +$1.65M ﹤0.01% 2195
2024
Q3
$9.53M Buy
95,253
+30,656
+47% +$3.07M ﹤0.01% 2302
2024
Q2
$5.44M Buy
64,597
+7,486
+13% +$631K ﹤0.01% 2547
2024
Q1
$4.17M Sell
57,111
-6,765
-11% -$495K ﹤0.01% 2720
2023
Q4
$4.56M Sell
63,876
-5,965
-9% -$426K ﹤0.01% 2663
2023
Q3
$4.18M Sell
69,841
-36,953
-35% -$2.21M ﹤0.01% 2603
2023
Q2
$7.7M Buy
106,794
+44,803
+72% +$3.23M ﹤0.01% 2244
2023
Q1
$4.56M Buy
61,991
+246
+0.4% +$18.1K ﹤0.01% 2616
2022
Q4
$4.12M Buy
61,745
+4,425
+8% +$296K ﹤0.01% 2765
2022
Q3
$3.08M Sell
57,320
-12,484
-18% -$671K ﹤0.01% 3023
2022
Q2
$3.89M Sell
69,804
-16,532
-19% -$920K ﹤0.01% 2884
2022
Q1
$6.06M Sell
86,336
-54,529
-39% -$3.83M ﹤0.01% 2654
2021
Q4
$13.6M Buy
140,865
+44,113
+46% +$4.25M ﹤0.01% 2045
2021
Q3
$8.41M Sell
96,752
-60,079
-38% -$5.22M ﹤0.01% 2401
2021
Q2
$12.8M Sell
156,831
-57,764
-27% -$4.73M ﹤0.01% 2066
2021
Q1
$20.4M Sell
214,595
-216,109
-50% -$20.6M 0.01% 1670
2020
Q4
$26.7M Buy
430,704
+264,739
+160% +$16.4M 0.01% 1359
2020
Q3
$9.87M Sell
165,965
-15,214
-8% -$905K ﹤0.01% 1950
2020
Q2
$12.6M Sell
181,179
-6,981
-4% -$487K ﹤0.01% 1803
2020
Q1
$8.54M Sell
188,160
-28,250
-13% -$1.28M ﹤0.01% 1894
2019
Q4
$14.1M Buy
216,410
+55,544
+35% +$3.61M ﹤0.01% 1846
2019
Q3
$9.99M Sell
160,866
-326,497
-67% -$20.3M ﹤0.01% 1939
2019
Q2
$34.7M Sell
487,363
-115,910
-19% -$8.25M 0.01% 1241
2019
Q1
$47.3M Buy
603,273
+121,334
+25% +$9.52M 0.01% 1048
2018
Q4
$40.8M Buy
481,939
+122,721
+34% +$10.4M 0.01% 1082
2018
Q3
$61.5M Sell
359,218
-231,699
-39% -$39.7M 0.02% 966
2018
Q2
$76.4M Buy
590,917
+163,937
+38% +$21.2M 0.02% 839
2018
Q1
$44M Buy
426,980
+71,526
+20% +$7.37M 0.01% 1137
2017
Q4
$30.4M Sell
355,454
-70,436
-17% -$6.02M 0.01% 1335
2017
Q3
$36.2M Sell
425,890
-14,215
-3% -$1.21M 0.01% 1246
2017
Q2
$33.3M Buy
440,105
+52,504
+14% +$3.98M 0.01% 1266
2017
Q1
$25.6M Buy
387,601
+116,402
+43% +$7.69M 0.01% 1399
2016
Q4
$17.2M Sell
271,199
-81,952
-23% -$5.19M ﹤0.01% 1561
2016
Q3
$22.5M Buy
353,151
+303,476
+611% +$19.3M 0.01% 1409
2016
Q2
$3.7M Buy
49,675
+14,454
+41% +$1.08M ﹤0.01% 2289
2016
Q1
$2.35M Buy
35,221
+20,783
+144% +$1.39M ﹤0.01% 2430
2015
Q4
$977K Sell
14,438
-45,851
-76% -$3.1M ﹤0.01% 2911
2015
Q3
$3.22M Sell
60,289
-87,565
-59% -$4.68M ﹤0.01% 2266
2015
Q2
$9.31M Sell
147,854
-442,007
-75% -$27.8M ﹤0.01% 1720
2015
Q1
$28.4M Buy
589,861
+258,000
+78% +$12.4M 0.01% 1159
2014
Q4
$11M Sell
331,861
-12,843
-4% -$426K ﹤0.01% 1565
2014
Q3
$10.1M Buy
344,704
+21,985
+7% +$644K ﹤0.01% 1605
2014
Q2
$12.5M Buy
322,719
+119,326
+59% +$4.64M ﹤0.01% 1506
2014
Q1
$8.54M Sell
203,393
-44,944
-18% -$1.89M ﹤0.01% 1682
2013
Q4
$8.15M Buy
248,337
+123,279
+99% +$4.05M ﹤0.01% 1685
2013
Q3
$3.38M Buy
125,058
+15,041
+14% +$406K ﹤0.01% 2169
2013
Q2
$2.57M Buy
+110,017
New +$2.57M ﹤0.01% 2205